These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
358 related items for PubMed ID: 27633826
1. Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis. Birolo C, Zannin ME, Arsenyeva S, Cimaz R, Miserocchi E, Dubko M, Deslandre CJ, Falcini F, Alessio M, La Torre F, Denisova E, Martini G, Nikishina I, Zulian F. J Rheumatol; 2016 Nov; 43(11):2068-2073. PubMed ID: 27633826 [Abstract] [Full Text] [Related]
7. Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry. Zannin ME, Birolo C, Gerloni VM, Miserocchi E, Pontikaki I, Paroli MP, Bracaglia C, Shardlow A, Parentin F, Cimaz R, Simonini G, Falcini F, Corona F, Viola S, De Marco R, Breda L, La Torre F, Vittadello F, Martini G, Zulian F. J Rheumatol; 2013 Jan; 40(1):74-9. PubMed ID: 23118110 [Abstract] [Full Text] [Related]
17. Leflunomide is associated with a higher flare rate compared to methotrexate in the treatment of chronic uveitis in juvenile idiopathic arthritis. Bichler J, Benseler SM, Krumrey-Langkammerer M, Haas JP, Hügle B. Scand J Rheumatol; 2015 Aug 02; 44(4):280-3. PubMed ID: 25993023 [Abstract] [Full Text] [Related]